AU2001266119A1 - Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste - Google Patents

Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste

Info

Publication number
AU2001266119A1
AU2001266119A1 AU2001266119A AU6611901A AU2001266119A1 AU 2001266119 A1 AU2001266119 A1 AU 2001266119A1 AU 2001266119 A AU2001266119 A AU 2001266119A AU 6611901 A AU6611901 A AU 6611901A AU 2001266119 A1 AU2001266119 A1 AU 2001266119A1
Authority
AU
Australia
Prior art keywords
active principle
oral administration
unpleasant
taste
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266119A
Other languages
English (en)
Inventor
Thierry Vandamme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES CRINEX
Original Assignee
CRINEX LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRINEX LAB filed Critical CRINEX LAB
Publication of AU2001266119A1 publication Critical patent/AU2001266119A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001266119A 2000-06-08 2001-06-06 Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste Abandoned AU2001266119A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0007364 2000-06-08
FR0007364A FR2809958B1 (fr) 2000-06-08 2000-06-08 Composition pharmaceutique sous forme liquide destinee a l'administration par voie orale d'un principe actif, ayant un gout desagreable, notamment un gout amer
PCT/FR2001/001748 WO2001093834A1 (fr) 2000-06-08 2001-06-06 Composition pharmaceutique sous forme liquide destinee a l'administration par voie orale d'un principe actif, ayant un gout desagreable, notamment un gout amer

Publications (1)

Publication Number Publication Date
AU2001266119A1 true AU2001266119A1 (en) 2001-12-17

Family

ID=8851107

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266119A Abandoned AU2001266119A1 (en) 2000-06-08 2001-06-06 Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste

Country Status (6)

Country Link
EP (1) EP1286660B1 (de)
AT (1) ATE340558T1 (de)
AU (1) AU2001266119A1 (de)
DE (1) DE60123419D1 (de)
FR (1) FR2809958B1 (de)
WO (1) WO2001093834A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102020010237A2 (pt) * 2020-05-22 2021-12-07 Ouro Fino Saúde Animal Ltda Plataforma para mascaramento de sabor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2331458B (en) * 1997-11-21 2002-07-31 Gursharan Singh Moonga Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions

Also Published As

Publication number Publication date
WO2001093834A1 (fr) 2001-12-13
DE60123419D1 (de) 2006-11-09
FR2809958A1 (fr) 2001-12-14
EP1286660A1 (de) 2003-03-05
ATE340558T1 (de) 2006-10-15
FR2809958B1 (fr) 2005-01-14
EP1286660B1 (de) 2006-09-27

Similar Documents

Publication Publication Date Title
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
WO2001066093A3 (en) Sustained release ranolazine formulations
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
DE69519300D1 (de) Stabiles arzneimittel enthaltend oxaliplatin
EP1246608A4 (de) PHARMAZEUTISCHE ZUBEREITUNGEN ZUR VERABREICHUNG VON WIRKSTOFFEN MIT GERINGER WASSERLöSLICHKEIT
WO2001095899A8 (en) Pharmaceutical compositions comprising cannabidiol derivatives
IT1276689B1 (it) Forma farmaceutica solida ad uso orale
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
EP1186293A3 (de) Intermittierende Verabreichung eines Wachstumshormon-sekretionsförderers
WO2002048141A1 (en) Medicinal compositions improved in solublity in water
AU2003238221A1 (en) Ibuprofen suspension
AU1073400A (en) Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
CA2388322A1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
WO2002049607A3 (en) Flavoured oral drug delivery system
AU2001266119A1 (en) Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste
WO2000067723A3 (de) Darreichungsform zur applikation in körperöffnungen
WO2002009717A1 (fr) Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif
HK1045937A1 (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
WO1997035568A3 (en) Diclofenac/gamma-cyclodextrin inclusion compounds
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
WO1999043299A3 (en) Oral formulation for hydrophilic drugs
WO1999066902A8 (en) Injectable pharmaceutical formulations of partricin derivatives